AN-DTPA Drug Patent Profile
✉ Email this page to a colleague
When do An-dtpa patents expire, and what generic alternatives are available?
An-dtpa is a drug marketed by Jubilant Draximage and is included in one NDA.
The generic ingredient in AN-DTPA is technetium tc-99m pentetate kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m pentetate kit profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AN-DTPA?
- What are the global sales for AN-DTPA?
- What is Average Wholesale Price for AN-DTPA?
Summary for AN-DTPA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
DailyMed Link: | AN-DTPA at DailyMed |
US Patents and Regulatory Information for AN-DTPA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jubilant Draximage | AN-DTPA | technetium tc-99m pentetate kit | INJECTABLE;INJECTION | 017714-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |